✦ LIBER ✦

V39 Preserved serotonin transporter binding in de novo Parkinson’s disease: Negative correlation with the dopamine transporter

✍ Scribed by F. Wegner; K. Strecker; S. Hesse; G. Becker; M. Patt; P. Meyer; D. Lobsien; J. Schwarz; O. Sabri

Book ID: 118426263
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 48 KB
Volume: 1
Category: Article
ISSN: 2210-5336
DOI: 10.1016/j.baga.2011.01.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preserved serotonin transporter binding

Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter

✍ Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 880 KB

Striatal dopamine transporter binding in

Striatal dopamine transporter binding in Parkinson's disease associated with the LRRK2 Gly2019Ser mutation

✍ Ioannis U. Isaias; Riccardo Benti; Stefano Goldwurm; Michela Zini; Roberto Cilia 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

We measured striatal dopamine transporter binding using [(123)I]ioflupane and SPECT in patients with Parkinson's disease associated with the LRRK2 (PARK8) Gly2019Ser gene mutation (LRRK2-PD) and in gene-negative patients with idiopathic Parkinson's disease (IPD) of comparable disease duration and se

Pinhole SPECT imaging of dopamine transp

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

✍ Gerda Andringa; Benjamin Drukarch; John G.J.M. Bol; Kora de Bruin; Karolina Sorm 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Growth hormone response in low-dose apom

Growth hormone response in low-dose apomorphine test correlates with nigrostriatal dopamine transporter binding in patients with Parkinson’s disease

✍ S. Happe; T. Tings; W. Koch; J. Welsch; K. Helmschmied; P. C. Baier; J. Meller; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 116 KB

Midbrain serotonin transporters in de no

Midbrain serotonin transporters in de novo and L-DOPA-treated patients with early Parkinson’s disease – a [123I]-ADAM SPECT study

✍ J. C. Beucke; M. Plotkin; C. Winter; T. Endrass; H. Amthauer; G. Juckel; A. Kups 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB

Clinical correlation of the binding pote

Clinical correlation of the binding potential with123I-FP-CIT in de novo idiopathic Parkinson’s disease patients

✍ Valentina Berti; Alberto Pupi; Silvia Ramat; Eleonora Vanzi; Maria Teresa De Cri 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 315 KB